Pharmaceutical The Association of Foreign Pharmaceutical Manufacturers (AIPM), a trade association which unites more than 60 global drugmakers operating in the Russian market, has appealed to the country’s Federal Antimonopoly Service (FAS) to limit participation of a drug with the international non-proprietary name (INN) insulin glargine in tenders for public procurements in the Russian pharmaceutical market, according to recent statements by an official spokesman of the Association and some local media reports. 1 December 2020